4//SEC Filing
COLLAGENEX PHARMACEUTICALS INC 4
Accession 0001179110-07-008173
CIK 0001012270operating
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 9:25 AM ET
Size
9.1 KB
Accession
0001179110-07-008173
Insider Transaction Report
Form 4
Ford James Gregory
VP, Business Development
Transactions
- Exercise/Conversion
Options to Purchase Common Stock
2007-04-19−5,000→ 118,855 totalExercise: $6.46Exp: 2014-08-08→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2007-04-19$6.46/sh+5,000$32,300→ 5,000 total - Sale
Common Stock
2007-04-19$14.23/sh−5,000$71,150→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 5, 2006.
- [F2]Represents options granted by the Issuer pursuant to its 1996 Stock Option Plan on August 9, 2004. The options vest as follows: 14,000 shares subject to such options vested on August 9, 2005, 14,000 shares subject to such options vested on August 9, 2006, 14,000 shares subject to such options vest on August 9, 2007, 14,000 shares subject to such options vest on August 9, 2008 and 14,000 shares subject to such options vest on August 9, 2009.
- [F3]Includes multiple option grants with different prices and vesting dates.
Documents
Issuer
COLLAGENEX PHARMACEUTICALS INC
CIK 0001012270
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001012270
Filing Metadata
- Form type
- 4
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 9:25 AM ET
- Size
- 9.1 KB